Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks* * Preliminary findings of this study were presented at the 10th NC1-EORTC Symposium on New Drugs in Cancer Therapy, 1998
Titel:
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks* * Preliminary findings of this study were presented at the 10th NC1-EORTC Symposium on New Drugs in Cancer Therapy, 1998
Auteur:
Rothenberg, M.L. Kuhn, J.G. Schaaf, L.J. Rodriguez, G.I. Eckhardt, S.G. Villalona-Calero, M.A. Rinaldi, D.A. Hammond, L.A. Hodges, S. Sharma, A. Elfring, G.L. Petit, R.G. Locker, P.K. Miller, L.L. von Hoff, D.D.